Skip to content

Advertisement

Journal news

The KT Jeang Retrovirology prize 2018

New Content ItemRetrovirology awards the annual KT Jeang Retrovirology Prize to recognize outstanding achievements in the field by mid-career scientists.

It is with great pleasure that we announce the 2018 winner: Eric Freed.

An editorial briefly outlining the winner's achievements will be published shortly. 
Past winners are: S. Goff (2005), J. Sodroski (2006), K. Beemon (2007), B. Berkhout (2008), T. Heidman (2009), M. Malim (2010), M. Matsuoka (2011), M. Benkirane (2013), P. Bieniasz (2015), F. Kirchhoff (2016), and M. Emerman (2017).

Closing out 2017

As we near the end of an eventful year, both globally and for Retrovirology, it is fitting to announce at this time new developments for the journal. We say goodbye and a deeply felt thank you to Robin Weiss as Reviews Editor and welcome in his place Frank Kirchhoff who will be known to many of you and was a recent winner of the Retrovirology annual prize. Frank brings with him a wealth of high quality research experience in HIV. He has already begun to assemble a new thematic review series for the journal to follow on from the two that have begun to be published this year on HIV Latency (edited by Ben Berkhout and Alexander Pasternak) and Disruptive technologies in retrovirus research (edited by Johnson Mak).  

In another welcome addition to our team we are delighted to announce that David Margolis has joined as an Associate Editor. David is a leading expert in HIV latency and approaches to HIV cure which we all hope to be a topic that features strongly in Retrovirology in the coming few years. Read more about our two new Editors below. 

On these optimistic notes we thank all our contributors and reviewers and look forward to an exciting 2018!

New Content ItemProf. Dr. Frank Kirchhoff trained in Biology at the Georg-August-University in Göttingen and subsequently carried out his Diploma thesis at the German Primate Center in Göttingen. Thereafter, he performed post-doctoral training with Prof. Dr. Ronald Desrosiers at the NERPRC, Harvard Medical School, Boston. From 1994 to 2001, he was Lab Head of the Department of Virology at the University of Erlangen. In 2001, he joined the Institute of Virology at Ulm University Medical Center to become Associate Professor. Since 2009, he is Director of the newly funded Institute of Molecular Virology at Ulm University. His main interests are the pathogenesis of HIV/AIDS as well as innate immune defenses and mechanisms of viral evasion or counteraction by the viral accessory Vpu, Vpr and Nef proteins. Furthermore, the Kirchhoff group is interested in the discovery of novel endogenous factors affecting HIV and SIV infection and their optimization for basic research or clinical application.

New Content ItemProfessor David Margolis became interested in HIV as the pandemic emerged during his medical training. Trained at Tufts, the New England Medical Center, the Laboratory of Clinical Investigation at the NIH, and Program in Molecular Medicine at UMass, he has cared for people with HIV and studied the interactions between HIV and the host cell on the molecular level for his entire career. For nearly 2 decades, he and many collaborators have begun to understand the molecular basis of HIV latency, develop drug and immunotherapy approaches to target persistent HIV, to develop the tools needed to cure HIV infection.  He is the director of the UNC HIV Cure Center, funded in part by a public-private partnership between UNC and GlaxoSmithKline, principal investigator for the NIH-sponsored Collaboratory of AIDS Researchers for Eradication (http://www.delaneycare.org), and a professor of Medicine, and Microbiology & Immunology at the University of North Carolina at Chapel Hill.

19 December 2017

New Content Item

HIV cure – what does it mean?

In honor of World AIDS Day 2017, Dr Andrew Lever discusses the possibilities and complexities of a cure for HIV in this BMC On Medicine blog.

December 1st 2017 is the 30th anniversary of World AIDS Day. This year's theme is “Increasing Impact through Transparency, Accountability, and Partnerships”, reflecting how to increase our impact to move epidemics from crisis toward control. 
Read more from across BMC

1 December 2017

Welcome to new Editor-in-Chief Johnson Mak

We are delighted to announce that Dr Johnson Mak has been appointed Co-Editor-in-Chief of Retrovirology. Dr Mak is a well-known and highly respected figure in the retroviral field. He has been an Editor with the journal since 2004. Johnson brings a broad research expertise in HIV to the position as well as having a successful track record in scientific publishing.

 - Andrew Lever

24 July 2017

The KT Jeang Retrovirology prize 2017

Retrovirology awards the annual KT Jeang Retrovirology Prize to recognise outstanding achievements in the field by mid-career scientists, older than 45 but younger than 60. Nominees are evaluated by the Retrovirology Editors in what is always a very tight contest. The winner, who receives a trophy and a cheque of 2000 GBP, is announced in the journal with an accompanying editorial that briefly outlines the winner's achievements. Although we maintain strict confidentiality about nominees who did not win, many of them are also outstanding scientists who may well receive the prize in the future, testament to how much the Retrovirology Prize is truly valued by our community.

Past winners are: S. Goff (2005), J. Sodroski (2006), K. Beemon (2007), B. Berkhout (2008), T. Heidman (2009), M. Malim (2010), M. Matsuoka (2011), M. Benkirane (2013), P. Bieniasz (2015) and F. Kirchhoff (2016).

It is with great pleasure that we announce the 2017 winner: Michael Emerman.

Read this year's Editorial or view all previous winners.

26 June 2017

New Content Item

Welcome to new Associate Editor François Venter

We are delighted to welcome Professor François Venter to the Editorial team of Retrovirology. Professor Venter has been Associate Professor at the School of Clinical Medicine at the University of the Witwatersrand since 2009 and Deputy Executive Director of the Wits Institute, School of Clinical Medicine, University of the Witwatersrand since 2010. He has published extensively on clinical issues of pathogenesis and treatment of HIV/AIDS and he brings with him a vast wealth of clinical experience as well as an invaluable knowledge of HIV in resource poor settings. He broadens the subject expertise and the geographical reach of the journal and will be the focus for the extension of the remit of Retrovirology into the clinical arena. We look forward to combining the established expertise and high standards in laboratory research in retroviruses of our current editorial team with the exciting areas of clinical research where so many advances are now occurring and the word ‘cure’ is just starting to be mentioned in a more serious manner than ever has been the case previously.

23 May 2017

Dr Mark Wainberg

The Editors and Publisher of Retrovirology regret to announce the death of Dr Mark Wainberg, founding editor and latterly co-Editor-in-Chief.

 

All at the Journal wish to express their deepest sadness at his passing and send their condolences to his family and many close friends. You can read our obituary for Mark here.

14 April 2017

Frontiers of Retrovirology 2016

Read the full proceedings of the meeting's oral presentations, covering topics from 'innate sensing and intrinsic immunity' to 'adaptive immunity' and 'recent advances in HIV vaccine development'.

5 October 2016

2016 Journal Metrics

Advertisement